Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remidazolam for Colonoscopic Polypectomy in Elderly
NCT05801757Completed
- Sponsor
- Tongji Hospital
- Start
- May 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam (3 arms), sponsored by Tongji Hospital. Primary endpoint: Sedation success rate at 1 day. Started May 2023; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05801757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05801757.